SCHEMBL312740

SCHEMBL312740

CCOC(=O)Cc1cc(O)ccc1-c1cc(=O)c2ccc(O)cc2o1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.57
HPGD P15428 5/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TP53 P04637 2/20 0.51
ALOX15 P16050 1/20 0.51
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 2/20 0.49
GLA P06280 2/20 0.49
GAA P10253 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
CYP3A4 P08684 4/20 0.49
CYP19A1 P11511 2/20 0.49
MAOA P21397 2/20 0.49
MAOB P27338 2/20 0.49
QPCT Q16769 2/20 0.49
MPO P05164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312252 0.91 AKR1B1 (0.46) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL10215485 0.91 HPGD (0.59) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312410 0.91 CYP3A4 (0.52) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312442 0.86 BACE1 (0.62) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL311334 0.84 EGFR (0.46) HPGDKMT2ASMN1; SMN2TP53ALOX15
SCHEMBL311402 0.84 ATM (0.53) HPGDMEN1KMT2ASMN1; SMN2ALOX15
SCHEMBL311828 0.83 CYP2D6 (0.46) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL311962 0.80 EGFR (0.47) HPGDMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL312930 0.80 AKR1B1 (0.57) AKR1B1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL312117 0.79 TNKS (0.55) HPGDMEN1KMT2ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed